John Whalen, MD
Nephrology · Dubuque, IANPI 1285694802
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.5% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Novartis at 31.0% of the total. 2025 is the largest year on record at $67, 2.9 times the $23 reported in 2020. That places this record below the midpoint for nephrology clinicians in IA, where the typical reported total is $192.
Across 12 payments — averaging $9.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$34
- Otsuka America Pharmaceutical, Inc.$33
- Ardelyx, Inc.$16
- Baxter Healthcare$15
- Travere Therapeutics, Inc.$10
What the payments were for
- Food & beverage$9891%
- Education$109%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Ardelyx, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Travere Therapeutics, Inc. | 6 | $10 |
How this compares
$109 in reported general payments places this provider in the 40th percentile of 73 nephrology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 201 | $165,804 |
| Thiola EcTiopronin | 12 | $93,509 |
| FarxigaDapagliflozin Propanediol | 50 | $44,171 |
| EliquisApixaban | 75 | $41,999 |
| XphozahTenapanor Hcl | 13 | $37,753 |
| Sevelamer Carbonate | 164 | $33,999 |
| ClinolipidFat Emulsion/Olive/Soy/Phospho | 80 | $26,947 |
| RenvelaSevelamer Carbonate | 18 | $24,231 |
| ProsolParenteral Amino Acid 20% No.1 | 121 | $19,458 |
| JanuviaSitagliptin Phosphate | 30 | $18,443 |
| LokelmaSodium Zirconium Cyclosilicate | 22 | $10,431 |
| Calcitriol | 642 | $9,651 |
| Potassium Citrate ErPotassium Citrate | 56 | $8,186 |
| Potassium Chloride | 267 | $7,339 |
| Midodrine Hcl | 106 | $5,877 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Dubuque
- Andrew BlandDubuque$76K
- David RingoldDubuque$469
- Craig ShadurDes Moines$314K
- Lawrence HunsickerIowa City$70K
- Ashar LuqmanSioux City$56K
- Jeremy PepinCouncil Bluffs$42K
- Prem ChandranDes Moines$19K
- Lama NoureddineIowa City$7K
- Benjamin GriffinIowa City$6K
- Mony FraerIowa City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.